Across TCGA pan-cancer cohorts, COLEC10 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated COLEC10 data layer compared with 23 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher COLEC10 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated COLEC10 expression acts as an unfavorable survival marker.

LUAD, PDAC, and LSCC are the cancer types where COLEC10 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.397	0.885	<.001	82	view →
PDAC	DFS	Tertile	III,IV	0.168	0.872	.024	6	view →
LSCC	DFS	Median	III,IV	0.511	1.000	.024	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: COLEC10 tumor-vs-normal RNA expression · all COLEC10 data types